7 Co-Creation Finalists Invited to Pitch in Ingelheim

7 Co-Creation Finalists Invited to Pitch in Ingelheim

Imagen de Felicity McLean

What if the business sector and social entrepreneurs came together to co-create the next generation of sustainable health solutions that improve access to health? 

Over the past 5 months, Making More Health: Co-Creating a Healthier World has offered an opportunity for social entrepreneurs to spark the next generation of sustainable health solutions through collaboration with Boehringer Ingelheim. This global challenge seeks social innovations that have a person-centered (rather than product-centered) approach to health and the potential to scale up through a partnership with Boehringer Ingelheim, a global healthcare company.

In Phase 2 of the challenge, 47 qualifying entrants had the opportunity connect with Boehringer Ingelheim employees and members of the Making More Health network who are passionate about innovating for a better world. Entrants received support to develop solutions that combine the best of social innovation and business acumen. 42 of these 47 submitted a secondary entry form, which were pitched, discussed and deliberated by our core team of Making More Health Experts.  
We are delighted to welcome 7 fantastic Co-Creation teams to participate in our final leg of this pioneering global challenge. Phase 3 will see these Co-Creation teams participate in a 6-week Co-Creation Accelerator, where social entrepreneurs and Boehringer Ingelheim employees will work together to produce a Co-Creation business model canvas and prepare a pitch. All teams will receive a travel bursary to travel to Ingelheim, participate in a 2-day Making More Health Co-Creating a Healthier World Summit, and pitch their ideas to a panel of Boehringer Ingelheim judges for additional investment and implementation support. Winning pitches will receive cash prizes totaling $50,000 USD.


These teams are:

Changamka Microhealth (Kenya) - Insurance is poorly understood, unaffordable and inaccessible to the majority in developing countries. Changamka drastically lowers the cost of insurance by using mobile phones for innovative crowd funding demand generation, registration, payments, servicing and claims payment.

Co-Creation Idea:  Changamka are proposing to co-create with Boehringer Ingelheim a holistic micro-insurance package for 6 critical chronic illnesses (stroke, heart attacks, heart surgery, cancer, neurosurgery, organ transplant), targeting low-income “tier 2” patients in Kenya earning approximately 5 USD/day . Boehringer Ingelheim and Changamka would leverage Changamka’s developing partnership with the Munich Re group which would play the role of primary insurer and reinsurer and leading MNO, Safaricom. Changamka would oversee the client intake and management process, Safaricom would bring its client network and MPESA payment platform, Boehringer Ingelheim would bring its complementary disease expertise to build out additional value-add products & services around awareness, prevention and management for the critical 6 illnesses.


Community Veterinary Outreach (Canada) - Up to 25% of homeless people own pets & most place the needs of their pets ahead of their own. By providing preventive veterinary education and care to the animals of those in need, CVO improves not only the health of the animal, but also supports the physical and emotional well-being of their owners or guardians, and contributes to protecting public health.

Co-Creation Idea: Together, CVO and Boehringer Ingelheim would scale CVO’s One Health program model to Kansas City, MO, home of Boehringer Ingelheim’s US Animal Health Division headquarters. This co-creation expands CVO’s innovative healthcare delivery model leveraging the human-animal bond as a gateway to accessible human health services, thereby making more health for vulnerable people and their animal companions through veterinary care and community collaborations. With this co-creation together, CVO will be building Boehringer Ingelheim's brand recognition, demonstrating their core vision of “value through innovation”, attracting new talent and consumers, increasing employee loyalty and retention, and intrinsically motivating and engaging employees through community service and leadership opportunities.


Eau et Vie / Water and Life (France/Philippines) - By 2050, 40% of the urban growth will be in slums. There, families are not connected to the water distributors. Eau et Vie creates social business which builds a water network, equipped each household with an individual tap (connected to an individual meter) and collects the payments at home based on micro-credit systems.

Co-Creation Idea: In the slums, there is a high incidence of diabetes, hypertension and high blood pressure, within the communities Eau et Vie works in. Also, many individuals suffer from respiratory illnesses do to conditions created from cooking indoors with coal-burning stoves. These respiratory illnesses are intensified by a high instance of smoking. In response to these issues, Eau et Vie will benefit from Boehringer Ingelheim’s experiences, competencies in pharmaceutical sector to improve the health conditions of dwellers. Boehringer Ingelheim will provide to the communities adapted services and products. This partnership between social and business sector will permit to identify healthcare adaptations in urban areas.


Fight the Stroke (Italy) - Although stroke is perceived as occurring primarily among the elderly, it also strikes infants. Fight the Stroke has applied some of the most pioneering research on the human brain to improve care for young stroke victims using technology while empowering families.

Co-Creation Idea: FTS and Boehringer Ingelheim have identified a potential partnership in using the 'Mirrorable' solution for adult stroke survivors. Selling a Pill-Plus solution (drugs + rehab platform) through Boehringer's distribution channels could lead to incremental market effects, as better compliance and engagement of the patients, longer retentions and brand bondage within Boehringer Ingelheim, better motor outcomes for the patient and lower costs for healthcare providers. The business model: Subscription Model, the patient (out-of-pocket or via health insurance) will pay a fee to access the platform and run the rehab exercises. FTS and Boehringer will share the revenue incoming from the direct sales of the access to the solution. We could identify also different price points for different payers, while Boehringer Ingelheim could act as the customer paying for the model and then provide access to subscribers (Doctors, patients, medical institutions).


Garbage Clinical Insurance (Indonesia) - Garbage Clinical Insurance (GCI) is a micro health insurance program which uses garbage as a financial resource in Indonesia. Communities pay clinical services by using garbage in an insurance scheme. This way, GCI opens doors to health access because health is fundamental human right.

Co-Creation Idea: Garbage Clinical Insurance (GCI) is a micro health insurance program which uses garbage to pay insurance scheme. The community mobilize their unused resources to finance fully operating healthcare service, thus improving health access and environmental condition (reducing waste burning/ littering). With Boehringer Ingelheim (BI), we hope to replicate GCI globally. With this model, Boehringer Ingelheim can provide affordable health service through community-based healthcare facility, and improve local sanitation through community-based waste management (thus making more health). This model ensure sustainability and cost-effectiveness, in comparison to building a charity-based conventional clinic. Business wise, this opens new distribution channel for Boehringer Ingelheim products to low income market.


MicroClinic Technologies: Blue Angel Network (Kenya) - Patients living in low-income peri-urban or rural communities are forced to travel long distances to access care. ZiDi™ is a software developed for point-of-care (POC) tracking of commodities in clinics serving rural and peri-urban communities in Kenya. We are scaling a network of trained youth, Blue Angels, to promote ZiDi™ and improve availability, accessibility, quality and affordability medicines.

Co-Creation Idea: MicroClinic Technologies is eager co-create with Boehringer Ingelheim (BI) to improve last mile diagnosis and treatment of cardiovascular disease (CVD) and stroke in five underserved regions in Kenya. ONE HUNDRED Private clinics serving densely populated peri-urban dwellings will be trained on a cardiovascular disease (CVD) screening protocol, which would be co-designed with Boehringer Ingelheim and embedded in the MicroClinic’s existing ZiDi™ health management software. The screening protocol will be reinforced by a coupon/loyalty program, where clinics earn points for adhering to the CVD protocol that can then be converted into coupons for the purchase of electro cardiogram devices to better serve patients.

Noora Health (India) - Patients & caregivers around the world face a similar need–after a major diagnosis, surgery or health event, they are left to care for a family member but do not have the health information, resources or training they need. By training families with simple, low-risk skills, Noora Health enables at-risk families to provide high quality care in the hospital and at home.

Co-Creation Idea: Noora Health and Boehringer Ingelheim have identified the need for more comprehensive patient and family education tools for Chronic Obstructive Pulmonary Disease (COPD). What if upon diagnosis of COPD, patients were able to have access to critical information pertaining to the disease, how to manage their health and a good understanding of the medication they are prescribed with in a language that they are most comfortable with? COPD is one of the main drivers of mortality in India, where rates are estimated to be among the highest in the world. Similarly, in Canada, COPD is a leading cause of mortality and morbidity, with prevalence rates of roughly 4%. Unlike other chronic disease states (such as diabetes, heart disease), patient-facing information on COPD is incredibly limited. Noora Health would work with Boehringer Ingelheim to develop comprehensive family caregiver and patient-facing tools to be used among non-English speaking patients in both Canada and India to help families understand and manage their condition.